This Article Free Full Text Free Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Matsui, K. Articles by Okumura, T. Search for Related Content PubMed PubMed Citation Articles by Matsui, K. Articles by Okumura, T. Social Bookmarking                         What's this?

Effect of Active Hexose Correlated Compound on the Production of Nitric Oxide in Hepatocytes

Kosuke Matsui, MD, PhD^*, Yusai Kawaguchi, MD, PhD^*, Takashi Ozaki, MD, PhD^*, Katsuji Tokuhara, MD^*, Hironori Tanaka, MD^*, Masaki Kaibori, MD, PhD^*, Yoichi Matsui, MD, PhD^*, Yasuo Kamiyama, MD, PhD^*, Koji Wakame, PhD, Takehito Miura, PhD, Mikio Nishizawa, MD, PhD and Tadayoshi Okumura, PhD

From the ^* Department of Surgery and the Department of Medical Chemistry, Kansai Medical University, Moriguchi, Osaka, Japan; and the Amino Up Chemical Co Ltd, Sapporo, Japan

Correspondence: Tadayoshi Okumura, PhD, Department of Medical Chemistry, Kansai Medical University, 10–15 Fumizonocho, Moriguchi, Osaka 570-8506, Japan. Electronic mail may be sent to okumura{at}takii.kmu.ac.jp.

Background: Active hexose correlated compound (AHCC) is a "complex compound" containing polysaccharides. AHCC has been reported to improve the prognosis of postoperative hepatocellular carcinoma patients. However, the molecular mechanism of this improvement is not fully understood. In the diseased liver, nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS) is considered to be a causal factor for various hepatopathies. In this study, the possibility of AHCC regulation of NO production by iNOS was pursued as a potential liver-protecting mechanism. Methods: Primary cultured rat hepatocytes were treated with interleukin-1β (IL-1β) in the presence or absence of AHCC. NO production, iNOS induction, and iNOS signal were analyzed. Results: IL-1β stimulated iNOS induction through the activation of nuclear factor B (NFB), leading to NO production. The addition of AHCC inhibited NO production, showing >80% inhibition at 8 mg/mL. AHCC also decreased the levels of iNOS protein and mRNA. However, AHCC influenced neither the degradation of inhibitory protein B (IB) nor the activation of NFB stimulated by IL-1β. Transfection experiments with an iNOS promoter-luciferase construct (iNOS-Luc) revealed that AHCC had no effect on the transactivation activity of the iNOS promoter. By contrast, AHCC inhibited the activity of iNOS-Luc containing a 3'untranslated region (UTR) with adenosine and uridine (AU)–rich elements, which shows the stabilizing activity of iNOS mRNA. Conclusions: Results indicated that AHCC inhibits the induction of iNOS at the level of transcription, causing a decrease in NO production in hepatocytes. AHCC seems to decrease the levels of iNOS mRNA by reducing mRNA stabilization rather than inhibiting its synthesis.

Discussant

Author's Response

Journal of Parenteral and Enteral Nutrition, Vol. 31, No. 5, 373-381 (2007)
DOI: 10.1177/0148607107031005373


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?